Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.19.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]    
Revenues $ 318 $ 239
Cost of revenues 158 88
Gross profit 160 151
Operating expenses:    
Research and development 614 693
Selling and marketing 1,212 465
General and administrative 2,637 2,084
Total operating expenses 4,463 3,242
Operating loss (4,303) (3,091)
Financial expense, net (Note 12) 22 1,836
Loss before taxes on income (4,281) (4,927)
Tax Benefit (taxes) on income 127 (38)
Net Loss (4,154) (4,965)
Deemed dividend related to extension of February 2015 warrants to Common stock in January 2017 841
Total loss attributable to holders of Common stock, Preferred C stock and Preferred D stock $ (4,154) $ (5,806)
Common stock, Preferred C stock and Preferred D stock basic and diluted net loss per share (Note 2q) (in dollars per share) $ (0.64) $ (1.17)
Weighted average number of shares of Common stock, Preferred C stock and Preferred D stock used in computing basic and diluted net loss per share (Note 2q) (in shares) 6,448,343 4,964,077